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Two factor-based reprogramming of rodent
and human fibroblasts into Schwann cells
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Schwann cells (SCs) generate the myelin wrapping of peripheral nerve axons and are
promising candidates for cell therapy. However, to date a renewable source of SCs is lacking.
In this study, we show the conversion of skin fibroblasts into induced Schwann cells (iSCs) by
driving the expression of two transcription factors, Sox10 and Egr2. iSCs resembled primary
SCs in global gene expression profiling and PNS identity. In vitro, iSCs wrapped axons
generating compact myelin sheaths with regular nodal structures. Conversely, iSCs from
Twitcher mice showed a severe loss in their myelinogenic potential, demonstrating that iSCs
can be an attractive system for in vitro modelling of PNS diseases. The same two factors were
sufficient to convert human fibroblasts into iSCs as defined by distinctive molecular and
functional traits. Generating iSCs through direct conversion of somatic cells offers opportu-
nities for in vitro disease modelling and regenerative therapies.
DOI: 10.1038/ncomms14088 OPEN
1 Division of Neuroscience, San Raffaele Scientific Institute, 20132 Milan, Italy. 2 University of Milano-Bicocca, 20126 Milan, Italy. 3 Division of Neuroscience,
Axo-glia Interactions Unit-INSPE, San Raffaele Institute, 20132 Milan, Italy. 4 Department of Clinical and Biological Sciences, and Cavalieri Ottolenghi
Neuroscience Institute, University of Turin, Ospedale San Luigi, 10043 Orbassano, Turin, Italy. 5 SR-Tiget, Division of Regenerative Medicine, Stem Cells and
Gene Therapy, San Raffaele Scientific Institute, 20132 Milan, Italy. 6 Department of Neurology, Neurophysiology and Neurorehabilitation Unit-INSPE, San
Raffaele Scientific Institute, 20132 Milan, Italy. 7 Department of Neurology, Neuropathology Unit-INSPE, San Raffaele Scientific Institute, Via Olgettina 48,
20132 Milan, Italy. 8 National Research Council (CNR), Institute of Neuroscience, 20129 Milan, Italy. Correspondence and requests for materials should be
addressed to V.B. (email: broccoli.vania@hsr.it).
NATURE COMMUNICATIONS | 8:14088 | DOI: 10.1038/ncomms14088 | www.nature.com/naturecommunications 1
S
chwann cells (SCs) are neural crest-derived cells able to
produce the myelin sheaths, wrapping neuronal axons in
the peripheral nervous system (PNS). When peripheral
nerves are injured, SCs adaptively respond by supporting
and stimulating tissue regeneration1. Nevertheless, after severe
nerve injuries or in genetic and metabolic myelin disorders, the
loss of myelin ensheathing axons cannot be replaced, leading
to disabling sensory defects and motor dysfunctions2,3. A valuable
therapeutic option for the treatment of peripheral nerve insults
is represented by the transplantation of SCs, alone or in
combination with the nerve guide4,5. However, this therapeutic
approach is strongly limited by the current lack of a renewable
source of SCs in humans.
Isolation of primary cultures of myelin-competent SCs works
very poorly in mice and humans6 and methods currently
available for differentiating SCs from pluripotent stem cells are
time-consuming, technically complex and generate SC precursors
with unproven myelination potential7. Generation of SCs has
been recently obtained through differentiation of somatic
progenitor cells8,9. Nonetheless, these approaches are limited by
the need of isolating rare progenitor cells in tissues. Moreover,
most of these methods are laborious and generate SCs with low
myelination efficiency that strongly limits the development of
cell-based therapies and in vitro disease-modelling studies. To
overcome these limitations, we speculated that a direct cell
conversion approach to convert skin fibroblasts into SCs would
offer a more straightforward and convenient procedure. Supra-
physiological expression of defined sets of developmental neural
transcription factors (TFs) is sufficient to impose a neural identity
to somatic cells in a rapid and single-step procedure, generating
induced neurons and glial cells with mature morphological and
functional properties10–14. In particular, TF-mediated
reprogramming can be applied to generate induced
oligodendrocyte precursor cells that express appropriate OPC
markers, produce myelin sheaths in vitro and sustain myelin
regeneration in mouse brains with genetic dysmyelination15,16.
Importantly, induced oligodendrocyte precursor cells were shown
to lack Myelin protein zero (MPZ) protein, a specific SC marker,
and myelinated multiple axons confirming their central, and not
peripheral, glial cell identity15,16. We, therefore, sought to
determine whether SCs could be generated by direct lineage
conversion from readily available somatic lineages such as
fibroblasts. We identified two factors sufficient to convert
rodent fibroblasts into SCs with molecular PNS identity and
competent to generate compact and functional myelin sheets. The
same factor combination could be used to promote conversion of
human post-natal fibroblasts into SCs with comparable properties
and functions.
Results
Two TF-based reprogramming of fibroblasts into SCs. Over the
last decade, an intertwined regulatory network has been shown to
have a critical role in promoting PNS myelination and its
maintenance17,18. We selected Sox10, Pou3f1 (known also as
Oct6), Egr2 (known also as Krox20) and Brn2 for their cardinal
role during SC myelination as good candidates for cell lineage
reprogramming19. To this end, the factors were individually
cloned in doxycycline (dox)-inducible lentiviral vectors and
E15.5 mouse embryonic fibroblasts were infected with one or
more lentiviruses and cultured in a SC culture medium
supplemented with Neuregulin-1 (NRG1) and forskolin (Fsk)
(Fig. 1a)20. At first, we realized that primary cultures of
embryonic and adult skin fibroblasts often contain a fraction of
CD271þ cells with neural crest stem cell features and can give
rise to SC precursors (Supplementary Fig. 1a,b)21. Thus, before
each reprogramming experiment, primary fibroblast cultures
were selected against CD271þ cells by flow-cytometry with
a stringent gating selection (Supplementary Fig. 1c). To evaluate
the SC lineage conversion, we monitored for the concomitant
activation of S100 and O4, both highly expressed in SCs, likely in
an immature state, while undetectable in fibroblasts. Fourteen
days in vitro (DIV) after viral-mediated gene transfer the
amount of double S100/O4 positive cells was scored with
the different TF combinations (Supplementary Fig. 1d,e).
Interestingly, we found that Sox10 combined with Egr2
expression produced the highest amount of S100þ /O4þ cells
(12.3±3.1% of total population, n¼ 8 independent experiments.
Values are means±s.d.) (Fig. 1b,c and Supplementary Fig. 1d,e).
The eventual addition of either Pou3f1 or Brn2 as a third factor
did not further increase the yield of S100/O4 expressing cells
(Supplementary Fig. 1e). Conversely, tTA infected or not infected
(control) fibroblasts did not show detectable expression of either
SC marker (Fig. 1b, inset). To better examine the reprogrammed
cell fraction, we isolated the O4þ cell population by
flow-cytometry (Fig. 1d) and expanded the culture for the
following analysis. Candidate gene expression analysis of the
Sox10/Egr2 reprogrammed cell progeny revealed a strong
activation of several SC markers, such as Erbb2, Erbb3, Cnx32,
Pmp22 and Mpz (also known as P0) (Fig. 1e)22. Likewise,
Mpz protein was readily detectable by immunostaining in the
great majority of the S100þ /O4þ cellular fraction as it
is normally found in somatic peripheral SCs, but not in
CNS oligodendrocytes (Fig. 1g–i)22. Conversely, sorted cells did
not express oligodendrocytes-specific transcription factors and
markers such as Olig1 and Olig2, Mog, Myrf (Mrf), Ng2 and
Nkx2.2 (Fig. 1f) confirming their PNS regional identity. In
addition, endogenous Sox10 and Egr2 were expressed in
transduced fibroblasts indicating that crucial components of the
SC gene regulatory network were reactivated in the Sox10/Egr2,
but not tTA, infected cells. (Fig. 1e). In accordance, known direct
target genes of Sox10 and Egr2 during SC development
and myelination such as Prx, Erbb3 and Mpz, were strongly
activated as confirmed by quantitative reverse transcription
PCR (qRT–PCRs) (Supplementary Fig. 1f)23. Importantly,
silencing of the two lentiviral transgenes by dox withdrawal
for 2 weeks did not alter the expression of S100 and O4,
indicating a stable expression of these SC markers independently
by the reprogramming process (Supplementary Fig. 1g). Thus,
given the strong activation of the crucial factors distinctive for the
SC lineage and their subsequent maintenance even after transgene
expression silencing, we named the Sox10/Egr2 reprogrammed
fibroblasts as induced Schwann cells (iSCs). The two factors were
also effective in reprogramming neonatal and adult murine skin
fibroblasts generating S100þ /O4þ iSCs with an efficiency of
8.5±3.1% and 18.9±5.3% of total population, respectively
(n¼ 4) (Supplementary Fig. 2). Despite the driving force of the
reprogramming factors, the culture conditions proved to be
critical for the subsequent survival of the reprogrammed cells. In
particular the depletion of both NRG1 and Fsk, but not Fsk alone,
caused a strong reduction in the number of S100/O4/Mpzþ iSCs
due to a significant increase in cell death (Supplementary Fig. 3).
Transcriptional profiling of iSCs. Given that the establishment
of pure and highly proliferating SC cultures is often obtained
starting from neonatal rats, we wondered whether our method
could be applied in other species rather than the mouse. Rat
neonatal fibroblasts were converted into iSCs by the two-factor
expression with similar efficiency and dynamics compared to
mouse cells (Supplementary Fig. 4a,b). Fluorescence-activated cell
sorting-isolated rat O4þ iSCs showed an elongated bipolar
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shape and resulted immunodecorated for S100 and Mpz in most
cases (Supplementary Fig. 4c–e). Thus, in vitro cultures of
purified rat O4þ iSCs, their respective fibroblasts of origin
and somatic SCs were profiled for genome-wide expression by
next-generation sequencing analysis of total RNA (RNA-seq).
Remarkably reprogrammed and somatic SCs, but not fibro-
blasts, display strong correlation as assessed by unsupervised
hierarchical clustering (UHC), principal component analysis
and correlation of gene expression patterns (Fig. 2a,b and
Supplementary Fig. 5a). Differential gene expression analysis
showed about 4,000 transcripts differentially expressed between
either iSCs or SCs versus fibroblasts. Of note, a large set of
the differentially expressed genes (DEGs) was shared by the
two SC populations (Fig. 2c). Moreover, gene ontology
analysis revealed functional enrichment for multiple biological
pathways invaluable for SC biology (Fig. 2d). Furthermore, by
considering only those genes/microRNAs known to be pivotal
for SC development, UHC clustered together iSCs and somatic
SCs, thus confirming the similarities between the two cell types
(Fig. 2e,f). Accordingly, qRT–PCR analysis confirmed that both
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Figure 1 | Direct conversion of mouse skin fibroblasts into iSCs. (a) Schematic representation of the reprogramming strategy for generating iSCs using
the dox-inducible lentiviral transgenes expressing tTA, combinations of transcription factors (TFs) together with the small molecules NRG1 and Fsk.
(b) S100 (green) and O4 (red) immunofluorescence staining of Sox10/Egr2 (SE) or tTA-infected (inset) MEFs. (c) Quantification of S100þ and
S100þ/O4þ cells expressed as percentage over the total number of cells in experimental (SE) and control (tTA) conditions at 14 DIV (Mean±s.d., n¼8
independent experiments, 10 randomly selected 20 fields per sample were examined). (d) Fluorescence-activated cell sorting-based purification of the
O4þ iSC population. (e) Expression of SC cardinal markers by RT–PCR in fibroblasts (Fib), induced SCs and adult sciatic nerve (SN, positive control).
Sox10e, endogenous Sox10, Egr2e, endogenous Egr2. (f) Expression of Oligodendrocyte-specific markers by RT–PCR in fibroblasts (Fib), induced SCs,
sciatic nerve (SN) and P20 spinal cord (SpC, positive control). (g) S100/O4 and S100/MPZ immunofluorescence staining in iSCs. (h,i) Quantification
of 14 DIV iSCs expressing S100, O4 and MPZ alone or in combination (Mean±s.d., n¼6 independent experiments, three coverslips/experiment/antigen,
10 randomly selected 20 fields per sample were examined). ***Po0,001; Student’s t-test. Scale bars, 50mm.
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Figure 2 | Comparative transcriptomic analysis of iSCs, primary SCs and fibroblasts of origin. (a) Heat-map of the unsupervised hierarchical clustering
(UHC) of 2,500 random genes for fibroblasts and somatic and induced Schwann cells. The correlation between samples is shown as a dendrogram on top
of the picture. (b) Principal component analysis showing the first three components, explaining about 75% of the total variance. (c) Venn diagram showing
the overlap between the differentially expressed genes (DEGs) comparing Schwann and iSchwann cells versus fibroblasts. (d) Functional enrichment
analysis of the DEGs. (e,f) UHC of somatic SC-specific genes/microRNAs in the three cell populations. (g) Volcano plots showing the distribution of
SC- and fibroblast-specific genes in the two conditions. (Chi-square test SC-specific genes P¼0.94; Chi-square test fibroblast-specific genes P¼0.81)
(h) Volcano plots showing the distribution of the genes perturbed upon exposure to NRG1/Fsk in the two comparisons (Chi-square test P¼0.82).
(i) UHC of fibroblast-specific genes in the three cell populations.
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SC derivatives showed comparable levels of many SC-enriched
transcripts, including Cnp, Erbb3, GalC, Mal, Mapk3, Mbp, Mpz,
Pmp22 and Pou3f1 (Supplementary Fig. 5b). To corroborate
the similarities between the two SC types, we filtered for
those genes physiologically relevant in SCs during development24
and subdivided SC- and fibroblast-specific DEGs according to
fold change and statistical significance. Noteworthy, analysis of
the DEG frequency distribution did not show any deviation of the
observed frequencies (iSCs) from the expected frequencies (SCs)
neither in SC- and fibroblast-specific DEGs, nor in SC developing
genes (Fig. 2g and Supplementary Fig. 5d). Similarly, analysis of
the DEG frequency distribution of those genes perturbed upon
exposure to the differentiating factors NRG1 and Fsk did
not show any deviation of the DEG frequencies (Fig. 2h)25.
UHC filtering for genes belonging to biological pathways relevant
for SC biology revealed an extensive clustering between iSCs and
SCs (Supplementary Fig. 5e–j). Conversely, iSCs showed a
consistent silencing of the genes specifically enriched in the
fibroblasts. In fact, UHC analysis of a representative array of
fibroblast-specific genes revealed that the majority of these were
either strongly downregulated or even completely silenced in iSCs
(Fig. 2i). These results were corroborated by qRT–PCR assays
showing that somatic and induced SCs exhibited comparable
levels of expression for randomly selected genes such as Col2a1,
Col5a2, Ecm1 and Prrx1 (Supplementary Fig. 5c). Of note, only
a minimal fraction of this class of genes (o5%), normally very
poorly detectable in somatic SCs, were still expressed in 3-weeks
reprogrammed iSCs although to a reduced extent compared with
fibroblasts (Supplementary Fig. 5c). These results show that iSCs
do not represent a hybrid state of SCs and the donor cell type, but
instead exhibit a global transcriptional reconfiguration towards
the reprogrammed cell type with minimal signs of memory
at gene expression level of the cells of origin.
bFGF is a potent mitogen for iSCs. We, next, asked whether
additional molecules added during reprogramming could further
improve iSCs properties. We selected VEGF, basic fibroblast
growth factor (bFGF) and TGFb for their known role during
Schwann cell commitment and maturation26. Whereas with
VEGF and TGFb we did not observe any evident effect, in the
presence of bFGF, iSCs displayed a significant increase in cell
proliferation as shown by an increased number of Ki67þ cells
within the O4þ cell population (Fig. 3a,b). In addition, bFGF
treatment promoted a sustained proliferation rate over time in
iSC cultures (Supplementary Fig. 6). Importantly, bFGF-treated
cells strongly upregulated GFAP, a molecular marker of
immature SCs while significantly repressing the myelinating-
associated protein Mbp (Fig. 3c–e). In accordance, bFGF
sustained a global change in iSC morphology from mature
(with extensive lamellipodia) to immature (thin bipolar or
tripolar cells) cellular traits (Fig. 3f–i). Thus, the presence of
bFGF during the phase of cell expansion fostered a substantial
increase in the number of purified iSCs with an immature
morphology, Gfap expression and high proliferation rate
providing a convenient condition to expand iSCs for multiple
passages (tested up to P7) in vitro.
iSCs are efficient in generating myelin in vitro. To determine
the myelinogenic potential of iSCs in vitro, we adapted
a co-culture system using mouse dorsal root ganglion (DRG)
neurons27,28. DRGs were allowed to develop an extensive axonal
network before seeding iSCs pre-treated with or without bFGF.
iSCs and DRG co-cultures were maintained for 4 weeks without
dox. Intriguingly, in all conditions iSCs, but not fibroblasts, were
able to generate Mbpþ myelin segments surrounding neuronal
axons (Fig. 4a and Supplementary Fig. 7a). However, bFGF-
stimulated iSCs produced a three-fold increase in the overall
amount of Mbpþ myelin segments reaching levels close to those
displayed by somatic SCs (Fig. 4b). Likewise also internodal
length was comparable between bFGF-stimulated iSCs
and primary SCs (Supplementary Fig. 7b). In all conditions,
iSC-derived myelin developed mature and well-organized
internodes as showed by the correct localization of the
paranodal Caspr protein and nodal voltage-gated sodium
channels (NaV)29 (Fig. 4c–f). Electron microscopy imaging
revealed the formation of multiple and compact myelin sheaths
around the axons confirming the correct structure of the iSC-
derived myelin (Fig. 4g,h). Electron microscopy analyses showed
also the presence of non-myelinating iSCs and pre-myelinating
iSCs (Supplementary Fig. 7c) indicating that these cells can
recapitulate the full behaviour of SCs during myelination.
Altogether, these results demonstrate that iSCs acquired a
remarkable myelination potential, in particular when previously
exposed to exogenous bFGF, generating myelin segments with a
correct morphology and organization.
iSCs from Twicher mice are impaired in myelin formation.
Setting a fast and straightforward method for the generation of
myelinating SCs is particularly attractive for in vitro disease
modelling, since their isolation from mouse tissues and
subsequent culture and differentiation is particularly laborious
and poorly efficient. Thus, to determine whether iSC
reprogramming could represent a useful platform to model
PNS pathology in vitro, we focused on the well-characterized
Twitcher (Twi) mouse model30,31, which carries a spontaneous
mutation inactivating the beta-Galactocerebrosidase (GALC)
gene function and closely recapitulates the disease manifes-
tations of the human globoid cell leukodystrophy (GLD, or
Krabbe’s disease), a severe neurodegenerative lysosomal storage
disorder. In GLD, lack of functional GALC results in the
accumulation of galactosylceramide (GALCER) and the toxic
lysolipid galactosylsphingosine (psychosine) mainly in CNS and
PNS myelinating cells, causing progressive demyelination and
neurodegeneration32,33. Nonetheless, models of in vitro
myelination are not yet available for this disease. Although Twi
primary skin fibroblasts displayed some pathological features
such as the expansion of the lysosomal compartment and
GALCER and psychosine accumulation (Supplementary Fig. 8),
they proliferated normally and could be reprogrammed into iSCs
at comparable efficiency with their wild-type (WT) counterparts
(Supplementary Fig. 9a,b). In addition, upon bFGF treatment Twi
and WT iSCs acquired a comparable morphology and growth
expansion (Fig. 5a,b and Supplementary Fig. 9c). However, only
Twi iSCs displayed significant psychosine accumulation when
compared with parental fibroblasts, and evident cytoplasmic
deposition of GALCER was observed in Twi iSC as compared
with WT counterparts (Fig. 5c–e and Supplementary Fig. 9d,e).
Intriguingly, Twi iSCs showed a remarkable immature morpho-
logy with a higher number of Ki67þ proliferating cells compared
with WT counterparts (Fig. 5h and Supplementary Fig. 9f,g).
Likewise, a higher number of Twi iSCs upregulated the immature
SC marker GFAP while repressing Mbp expression (Fig. 5f,g and
Supplementary Fig. 9h,i). These results are in line with a previous
study showing that in Twi mice SCs displayed immature features
and altered myelin sheath morphology34. Next, we assessed the
myelinogenic potential of Twi and WT iSCs in organotypic
cultures with explanted Twi and WT DRGs in different genotype
combinations (Fig. 5i). Intriguingly, co-cultures of both Twi
DRG and iSCs revealed a striking loss of MBPþ internodes and
those remaining exhibited a consistent reduction in average
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length compared with their counterparts in WT co-cultures
at 4 weeks (Fig. 5i, bottom right and top left, Fig. 5j,k and
Supplementary Fig. 10). In addition, clustering of sodium
channels was impaired suggesting alterations in the nodal
structures in Twi iSC-derived myelin (Fig. 5l, bottom right and
top left, Fig. 5m). Conversely, in association with Twi DRG, WT
iSCs did not reveal any alteration indicating that the loss of
GALC enzyme in axons is not affecting the morphological
features of the surrounding myelin (Fig. 5i top right and Fig. 5j,k).
To determine whether the observed functional defects in Twi SCs
could be eventually cross-corrected by WT cells, we co-cultured
Twi iSCs with WT DRGs and scored for the presence of
myelination defects. Remarkably, in the presence of WT DRGs,
the number of Mbpþ internodes and their length were
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significantly normalized and maintained over time in the
Twi iSC-derived myelin (Fig. 5i, bottom left, Fig. 5j,k, and
Supplementary Fig. 10). Similarly, correct localization of sodium
channels at the nodes was strongly ameliorated in these
co-cultures (Fig. 5l, bottom left, and Fig. 5m). These results
suggest that Twi iSC-related dysfunctions can be largely reverted
by WT DRGs. It is well known that lysosomal enzymes are
normally released in the extracellular space and can be re-uptaken
by neighbour cells (cross-correction)31,35. Our findings suggest
that in our experimental setting the functional GALC enzyme
produced by WT DRGs is available for metabolic cross-correction
of Twi iSCs. Indeed, previous studies showed that metabolic
cross-correction and reconstitution of enzymatic activity
mediated by WT NSCs was effective in rescuing critical
functions in Twi NSCs and mature progeny in vitro and
in vivo36,37. Altogether, these results provide evidence that the
iSC cellular platform is a powerful and flexible system where
investigating pathological mechanisms affecting SC biology and
myelination processes.
Sox10 and Egr2 drive reprogramming into human iSCs. Next,
we asked whether human fibroblasts of non-neural crest origin
could be reprogrammed into SCs. To this end, human postnatal
fibroblasts were transduced with Sox10 and Egr2 expressing
lentiviruses and cultured for 2 weeks in SC inducing medium. In
these conditions, 5±0.6% of the total cell population (n¼ 3
independent experiments. Values are means±s.d.) acquired a
strong expression of the two SC markers S100 and O4 (Fig. 6a,b).
Conversely, no S100þ /O4þ cells were detectable in tTA infected
or not infected fibroblast cultures (Fig. 6a, inset). We, then iso-
lated the O4þ iSC population by flow-cytometry (Fig. 6c and
Supplementary Fig. 11a,b) and grew the cells for 1 week without
doxycycline for the following analysis. Fluorescence-activated cell
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sorting-purified human iSCs (hiSCs) activated several SC markers
such as MBP, ERBB3, MAG, EGR2, SOX10 and, most impor-
tantly, MPZ (Fig. 6d–f; Supplementary Fig. 11c). Surprisingly,
differently from rodent iSCs, hiSCs exhibited a strong expression
of both GFAP and MBP (Fig. 6g). As expected, sorted cells did
not express oligodendrocyte-specific transcription factors and
markers such as MOG, OLIG1 and OLIG2, NG2 and NKX2.2
(Supplementary Fig. 11d), confirming also in this case the PNS
regional identity of iSCs.
To functionally characterize hiSCs we adapted the pseudopod
assay to study the paracrine effects of iSCs on DRG and
vice versa38. In this indirect co-culture setting SCs were
placed over a filter on the top of a Boyden chamber while the
DRGs seeded at the bottom of the multiwell (Supplementary
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Fig. 12a). Three DIV after co-culture, we evaluated the
DRG axonal projection area and the pseudopod formation
on the internal surface of the Boyden chamber. Interestingly,
DRGs, grown in the presence of the hiSCs and primary SC,
exhibited significantly longer axons compared with DRGs
maintained alone or with control fibroblasts (Fig. 6h, top lane
and Fig. 6i), indicating a dual positive paracrine effect between
iSCs and DRGs. Furthermore, alike primary SCs and different
from fibroblasts, hiSCs failed to extend pseudopods on the
internal surface of the Boyden chamber as expected by the
distance separating SCs and DRGs which precluded to convey
the contact-mediated juxtacrine signals (Fig. 6h, bottom lane
and Fig. 6j)39. Rat iSCs showed a comparable response in these
assays as both hiSC and somatic mouse SCs (Supplementary
Fig. 12b–d). Finally, to test the behaviour of the hiSCs to
juxtacrine signals, we established direct co-cultures between
hiSCs and mouse DRGs. Unfortunately, a reliable protocol
for the in vitromyelination of hSCs with primary neurons has not
yet been developed to date. For these reasons we focused on the
early stages of myelination, in which SCs form pseudopods to
take direct contact with axons. Interestingly, after 5 DIV of
co-culture, electron microscope imaging showed multiple
examples of iSCs contacting several axons and emanating
pseudopods to surround them, a behaviour normally observed
with rodent SCs in the early phase of myelination (Fig. 6k and
Supplementary Fig. 12e).
These data clearly indicated that the combination of Sox10 and
Egr2 transcription factors is also effective in reprogramming
human fibroblasts into induced SCs with an expression pattern
and cellular behaviour comparable to their somatic counterpart.
Discussion
Herein, we identified Sox10 and Egr2 as a unique combination of
factors necessary for the effective generation of myelinogenic iSCs
by the direct conversion of adult rodent fibroblasts. Remarkably,
transcriptome studies revealed a substantial equivalence in
the SC-specific molecular signature between somatic and
reprogrammed SC progenies with a prevailing epigenetic
silencing of the donor cell gene expression profile. Only a minor
fraction of specific fibroblast-specific genes (o5%) were found
still expressed in iSCs, although at reduced levels compared with
the donor cells. This might indicate that 3 weeks of reprogram-
ming in these conditions might not be sufficient to fully reshape
the activity of these gene loci. This finding is consistent with
previous observations in induced pluripotent stem and fibroblast-
to-neuron cell reprogramming, and suggests that the time in
culture after reprogramming is a critical factor for the pervasive
erasure of the donor cell epigenetic memory40,41. iSCs showed a
robust in vitro myelinogenic capacity generating with time
correctly structured and patterned myelin sheaths when co-
cultured with DRG neurons. To our knowledge, this is the first
time that MPZþ SCs with an extremely high myelinating
potential are obtained by cell reprogramming. The identification
of bFGF as a potent mitogen for iSCs is relevant for enabling the
effective expansion of a pure population of iSCs after isolation by
immune-purification. Interestingly, initial bFGF treatment also
strengthens subsequent iSC differentiation potential and its
associated myelin generating capability. This action of bFGF on
iSCs is in line with its crucial action in promoting the
commitment of immature SCs and maintaining their expansion
in vitro25. Thus, this condition uncovers the opportunity for
a large-scale production of iSCs to generate sufficient number of
functional iSCs that can be exploited for autologous cell
replacement therapies.
The fast and straightforward process to generate iSCs should
facilitate in vitro disease modelling of peripheral demyelination
disorders and axonal damage. In fact, these studies have
been hampered by the intrinsic challenge to isolate these
cells in high number and sufficient purity, in particular
from mice, in which the majority of the genetic models
for human diseases are developed. Herein, we provided a strong
proof of concept that Twi iSCs retained the cellular and metabolic
alterations described in peripheral nerve cells in vivo, which result
in significant reduced myelination capability and severe altera-
tions in myelin organization42,43. This setting enabled us to
validate a significant rescue of the pathological defects of iSCs by
the co-culture with WT DRGs. Further, we provided a direct
evidence of a non-cell autonomous mechanism of disease
correction likely relying on efficient uptake by Twi iSCs of
a functional GALC enzyme produced and secreted by WT DRGs
(cross-correction). This phenomenon provides the rationale
and is thought to underlie the remarkable beneficial effects of
cell and gene therapeutic approaches for lysosomal storage
disorders in mice and humans31,44. However, its direct
consequences were not yet corroborated in a physiological
in vitro model of myelination. Thus, iSCs might be exploited
as a useful platform to decipher the molecular mechanisms
controlling lysosomal enzymatic release and re-uptake in the
contest of normal and pathological SC biology and axonal
myelination. More in general, this system can result informative
for a broad spectrum of disease conditions.
The iSC direct reprogramming disclosed the opportunity to
establish the first strategy of autologous cell transplantation,
thereby circumventing immunogenicity, for peripheral nerve
injury.
Figure 5 | Disease related features of Twitcher (Twi) iSCs and derived myelin. (a) Immunofluorescence analysis for S100/O4 and S100/MPZ in O4
immune-purified O4þ Twi iSC population reprogrammed in the presence of bFGF. (b) Bar graphs showing percentages of S100, O4 and MPZ positive iSCs
cells after bFGF treatment or in naive conditions (Mean±s.d., n¼ 3 independent experiments, three coverslips/experiment/antigen, 10 randomly selected
20 fields per sample were examined). (c) Representative immunofluorescence pictures for Lamp1 (green) and the lipid metabolite GALCER (red)
staining in WTand Twi iSCs. (d) Bar graph showing the Lamp1 positive area relative to the total nuclei in Twi iSCs, expressed as fold change (Mean±s.d.,
WTand Twi n¼ 2 independent lines, three coverslips/line, 10 randomly selected 20 fields per coverslip were examined). (e) Mass-spectrometry-based
quantification of psychosine (Psy) in WT and Twi iSCs (Mean±s.d., WT and Twi n¼ 2 independent lines, three samples per line were examined).
(f) Representative immunofluorescence images for GFAP in WT and Twi iSCs. (g) Quantification of GFAPþ cells in WT and Twi iSCs (Mean±s.d., n¼ 3
independent experiments, three coverslips/line, 10 randomly selected 20 fields per sample were examined). (h) Quantification of S100þ WTand Twi
iSCs with immature (IM) morphological traits (Mean±s.d., n¼ 3 independent experiments, 10 randomly selected 20 fields per sample were examined).
(i) Representative low-magnification pictures of MBP immunostaining to label myelin internodes of iSCs co-cultured with DRG neurons in different
combinations between WTand Twi genotypes. (j,k) Quantification of the number (j) and length (k) of MBPþ internodes in the four different combinations
of iSCs and DRG neurons from WT or Twi genotypes (Mean±s.d., n¼ 2 independent experiments, 4–8 coverslip/experiment, 10 randomly selected
20 fields per coverslip were examined). (l) Representative immunofluorescence pictures and quantification (m) of the NaVþ myelin nodes generated
after 4 weeks of by co-culture of iSCs with DRG neurons from either WT or Twi genotypes (Mean±s.d., n¼ 2 independent experiments, four coverslip/
experiment, 10 randomly selected 20 fields per coverslip were examined). *Po0,05; **Po0,01; ***Po0,001; Student’s t-test (b,d,e,h,g); One-way
ANOVA with Bonferroni correction (j,k,m). Scale bars, 50mm (a,c,f); 500mm (i); 20mm (l).
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Importantly, the same minimal combination of two factors
triggered the conversion of postnatal human fibroblasts into
hiSCs. Despite the low reprogramming efficiency, hiSCs could be
purified for O4 expression to establish enriched hiSC cultures.
Thus, this approach provides a fast and easy protocol to produce
hiSCs for biomedical studies. The hurdles experienced in the
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past in obtaining hSCs have hindered the development of
protocols for in vitro myelination and in vivo transplantation.
hiSC generation opens new opportunities to advance experi-
mental methodologies using human cells. This is the first
evidence of the generation of reprogrammed SCs endowed with
a robust myelinogenic potential suitable for informative in vitro
studies on physiological and pathological mechanisms of myelin
formation/maintenance in peripheral nerves. Therefore, our
findings represent a crucial step for the potential future
application of iSCs in human PNS disease biology and therapy.
Methods
Cell culture. MEFs were isolated from E13.5 wild-type and GALC-deficient
Twitcher mice (mixed C57BL6/FVB background; referred to as Twi mice in this
study) mice embryos. Head, vertebral column, dorsal root ganglia and all internal
organs were removed and discarded and the remaining embryonic tissue was
manually minced and incubated in 0.25% trypsin (Sigma) for 10–15min for cell
dissociation. Cells from each embryo were plated onto a 15-cm tissue culture
dish in MEF media (Dulbecco’s modified Eagle medium (Invitrogen) containing
10% fetal bovine serum (FBS; Hyclone), non-essential amino acids (Invitrogen),
L-glutamine (Invitrogen), sodium pyruvate and penicillin/streptomycin (Invitro-
gen). In all experiments cells were used only within the second passage and not
split more than four times. Mouse neonatal and adult fibroblasts and rat neonatal
fibroblasts were isolated from tail tip samples. Tails were peeled, minced into 1mm
pieces, placed on culture dishes, and incubated in MEF media for 5 days.
Primary rat SCs were prepared as described45 and maintained in SC media
(Dulbecco’s modified Eagle medium (Invitrogen), 10% FBS (Hyclone), L-glutamine
(Invitrogen), 2.5 mM Forskolin (Fsk, Sigma Aldrich), 2.5 ngml 1 recombinant
human NRG1b1 (NRG1, EGF domain, R&D), until used.
MRC5 fibroblast cell line was acquired from ATCC (ATCC CCL-171) and
maintained in MEF media.
Mouse DRG was isolated from E14.5 wild-type and Twitcher embryos, and
established on collagen-coated glass coverslips as described46. Explants were cycled
with the anti-mitotic reagent 5-fluoro-2-deoxy-uridine to eliminate all non-
neuronal cells. Neuronal media was supplemented with 50 ngml 1 NGF (Harlan,
Bioproducts for Science) and, in some cases, 25 ngml 1 BDNF (PeproTech)
and 10 ngml 1 NT3 (Austral Biologicals). Rat SCs, Fibroblasts and iSCs
(200,000 cells/coverslip) were added to established explant cultures of
DRG neurons, and myelination was initiated by supplementing media with
50mgml 1 ascorbic acid (Sigma-Aldrich). Primary human SCs were obtained
by Dr K. Haastert-Talini47. Testing for Mycoplasma cell contamination was
routinely performed.
Molecular cloning and viral infection. Complementary DNAs (cDNAs) for
reprogramming transcription factors were cloned into lentiviral vectors under
the control of the tetracycline operator. Replication-incompetent, VSVg-coated
lentiviral particles were packaged in 293T cells. MEFs, neonatal and adult mouse
and neonatal rat fibroblasts were infected in MEF media. Sixteen to twenty hours
after infection, cells were switched into fresh MEF media containing doxycycline
(2mgml 1; Sigma). After 48 h medium was replaced with Schwann cell media
containing doxycycline. The medium was changed every 2–3 days for a further
12–22 days.
Immunocytochemical assays. For immunocytochemical analysis, 5 104 fibro-
blasts were plated on matrigel-coated glass coverslips the day before the infection.
Ten to twenty-eight days after viral infection cells were fixed for 20min at room
temperature (20–25 C) in 4% paraformaldehyde in PBS, permeabilized for 30min
in PBS containing 0.1% Triton X-100 and 10% normal goat serum, and incubated
overnight at 4 C in PBS containing 10% normal goat serum and primary
antibodies. Then cells were washed three times with PBS and incubated for
2 h at room temperature with secondary antibodies. Co-cultures were permeabi-
lized in methanol and stained as described previously48. A list of antibodies used
can be found in Supplementary Table 1. The percentages of the cells that were
positive to specific markers were determined from at least three independent
experiments for each condition. Images for quantification were selected randomly.
First, the number of 4,6-diamidino-2-phenylindole-positive nuclei was counted,
followed by counting the number of cells expressing the markers of interest in at
least five fields per condition. To quantify the immunopositive area (expressed in
pixels) pictures in each coverslip/sample were taken and the immunopositive area
was calculated using the ImageJ software and normalized on nuclear counts. Cells
from WT mice were used to set the signal threshold in the comparison between
WT and Twitcher samples.
RT–PCR analysis. RNA was extracted and purified with the RNeasy Mini kit
(QIAGEN). Two micrograms of RNA were reverse transcribed Transcriptor High
Fidelity cDNA Synthesis Kit (Roche). One twentieth of the reverse transcribed
cDNA was amplified in a 25 microlitres of reaction mixture containing Taq
polymerase buffer (Fisher BioReagents), 0.2mM dNTPs (Finnzymes OY, Espoo,
Finland), 0.4 micromolar each primer, 1U Taq polymerase (Fisher BioReagents).
Primers for gene expression analysis are listed in Supplementary Table 2. The
thermal profile consisted of a first denaturing step for 5min at 95 C, 30 cycles of
30 s at 95 C, 30 s at the specific annealing temperature (see Supplementary
Table 2) and 40 s at 72 C, followed by a final extension of 10min at 95 C.
RNA sequencing and bioinformatics analysis. Total RNA isolation was
performed with the RNeasy Mini Kit (QIAGEN). Libraries were prepared with the
TruSeq RNA Library Preparation Kit v2 (Illumina) and sequenced with the
Genome Analyser IIx (Illumina). Bioinformatics analysis was performed with the
GeneProf web-based software49,50. Sequence quality control and alignment to the
Rn5 reference genome were performed with TopHat 2.1.0 (ref. 51). Estimates of
gene expression levels were calculated with the Quantitate Gene Expression
module. Differential gene expression was performed with DESeq v2.6 (ref. 52).
Statistical analysis was performed with SPSS Statistics (IBM) software and GENE-E
(Broad Institute) web-based application. Functional enrichment analysis was
performed with FunRich53.
Electron microscopy. Electron microscopy analyses on Schwann cell–DRG
neurons myelinating co-cultures were performed as described previously54. Cells
were fixed in a solution containing 2.5% glutaraldehyde and 0.5% sucrose in 0.1M
So¨rensen phosphate buffer (pH 7.2) for 4–6 h. The specimens were then washed in
a solution containing 1.5% sucrose in 0.1M So¨rensen phosphate buffer for a period
of 6–12 h, post-fixed in 2% osmium tetroxide, dehydrated and embedded in
Glauerts’ embedding mixture. Semi-thin sections perpendicular were cut on an
Ultracut UCT ultramicrotome (Leica, Wetzlar, Germany), and stained with
toluidine blue. From the same tissue blocks, ultra-thin sections (50–70 nm) were
also cut using the same ultramicrotome and placed on copper grids. Grids were
then stained with uranyl acetate and lead citrate and observed on a JEM-1010
transmission electron microscope (JEOL, Tokyo, Japan) operating at 80 kV and
equipped with a Mega-View-III digital camera and a Soft-Imaging-System
(SIS, Mu¨nster, Germany) for the computerized acquisition of the images.
Determination of GALC activity. Cells were harvested, washed in PBS, lysed for
1 h in 10mmol l 1 sodium phosphate buffer, pH 6.0, containing 0.1% (vol/vol)
Nonidet NP-40, and subjected to sonication. These steps were performed at 4 C.
Protein content was measured using the Bradford Protein Assay kit with bovine
serum albumin as the reference standard. GALC activity is measured as previously
described55. Briefly, the assay is performed using 2–7.5 mg of sample proteins with
the artificial fluorogenic substrate 4-methylumbelliferone-b-galactopyranoside
(1.5mM) resuspended in 0.1/0.2mol l 1 citrate/phosphate buffer, pH 4.0, and
AgNO3 (11mM) at 37 C. The enzymatic reaction is stopped by adding 0.2M
pH 10.6 Glycine/NaOH. Fluorescence of liberated 4-methylumbelliferone is
measured on a spectrofluorometer (l ex 360 nm, l em 446 nm).
Psychosine dosage. Psychosine quantification was performed on frozen cellular
pellets by Dr W. Kulik (AMC, Amsterdam), as previously described56. Briefly,
dimethylpsychosine was added to cell-homogenates (0.2–0.5mg of protein) as
internal standard. After deproteinization and extraction by methanol:chloroform
and evaporation to dryness of the organic layer, the sample extract was
reconstituted in acidic methanol. After injection and elution over a C8 analytical
column, psychosine and its internal standard were detected by positive ESI in the
MRM mode on a TSQ Quantum AM mass spectrometer. Pychosine concentrations
were established by the use of calibration standards.
Pseudopod assay. Pseudopod assay was performed as previously described38.
with few modifications: mouse DRG neurons were plated on the bottom of
a 24-well plate. Cells (1.5 105) were starved for 12 h, and then trypsinized with
0.5% Trypsin–EDTA, pelleted, resuspended and plated into the upper
compartment of the Boyden chamber insert. We used 0.33 cm2 polycarbonate
transwell permeable inserts with 3 mm pores (Corning #3415) coated with matrigel.
Cells were maintained in Schwann cell media without doxycycline for 4 h at 37 C
to attach and spread on the upper surface of the insert. Then, inserts were washed
with PBS and transferred to a 24-well plate containing DRGs in a medium without
ascorbic acid. Pseudopods were allowed to grow at 37 C. After 3 days, the upper
surface of each membrane was cleaned with a cotton swab, and the pseudopods
that migrated into the lower surface were fixed in 4% paraformaldehyde and
stained with phalloidin (Alexa Fluor 594 phalloidin, Invitrogen). Filters were, next,
excised from the insert with microscissors and mounted on a slide for subsequent
imaging analysis.
Animals. Mice were maintained at San Raffaele Scientific Institute Institutional
mouse facility (Milan, Italy) in micro-isolators under sterile conditions and
supplied with autoclaved food and water. Sprague Dawley rats were housed in the
animal facility at the Neuroscience Institute ‘Cavalieri Ottolenghi’, c/o Ospedale
San Luigi, Orbassano, Turin, Italy. All procedures were performed according to
protocols approved by the internal IACUC and reported to the Italian Ministry of
Health according to the European Communities Council Directive 2010/63/EU.
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Statistical analysis. Statistical significance between two samples was determined
with Student’s t-test (GraphPad Prism 5; GraphPad). The statistical significance
among multiple samples was determined with one-way analysis of variance with
Bonferroni’s multiple comparison tests. The data were considered statistically
significant for Po0.05 and are shown as the mean±s.d. or s.e.m as indicated. All
data were acquired from at least three independent experiments.
Data availability. Microarray data have been deposited in the NCBI Gene
Expression Omnibus database under accession code GSE78712. The authors
declare that all data supporting the findings of this study are available within the
article and its Supplementary Information files or from the corresponding author
upon reasonable request.
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